Sanofi News News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sanofi news. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sanofi News Today - Breaking & Trending Today

AstraZeneca-Sanofi Beyfortus approved in Japan for prevention of RSV disease in infants

Cambridge: AstraZeneca and Sanofi s Beyfortus (nirsevimab), a long-acting monoclonal antibody, has been approved in Japan for the prophylaxis of lower respiratory tract disease (LRTD) caused by. ....

Hiroyuki Moriuchi , Iskra Reic , European Union , Japanese Ministry Of Health , Nagasaki University Graduate School Of Biomedical Sciences , Head Of Department Pediatrics , Japanese Ministry , Nagasaki University Graduate School , Biomedical Sciences , Executive Vice President , Immune Therapies , Astrazeneca News , Sanofi News , Respiratory Syncytial Virus , Dr Hiroyuki Moriuchi ,

Lupin to buy established products portfolio in Europe, Canada from Sanofi for Rs 91 crore

Under the agreement, Lupin will acquire brands AARANE in Germany and NALCROM in Canada and the Netherlands. ....

New Delhi , Lupin Ltd , Lupin Atlantis Holdings , Foreign Direct Investment Bureau Of Canada , Foreign Direct Investment Bureau , Lupin News , Sanofi News ,

Sanofi once-weekly Altuviiio approved in Japan for hemophilia A

Paris: Sanofi has announced that the Japanese Ministry of Health, Labor, and Welfare (MHLW) has granted marketing authorization for ALTUVIIIO [Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion. ....

Brian Foard , European Commission , Drug Administration , European Medicines Agency , Executive Vice President , Global Head , Specialty Care , Breakthrough Therapy , Fast Track , Orphan Drug , Marketing Authorization Application , Hemophilia A , Sanofi News ,

Nirsevimab delivers 83 percent reduction in RSV infant hospitalizations in a real world clinical trial setting: Sanofi

RSV is the most common cause of LRTD, including bronchiolitis and pneumonia, in infants. ....

United Kingdom , Thomas Triomphe , Simon Drysdale , George University Hospital , Antibody Prevention , Annual Meeting , European Society , Paediatric Infectious Diseases , Executive Vice President , Consultant Pediatrician , Infectious Diseases , University Hospital , Co Chief Investigator , Sanofi News , Clinical Trial ,

Sanofi ordered to pay over Rs 3 crore as compensation for epilepsy drug-related side effects

The court in Nanterre on Thursday ordered the company to compensate the parents of the girl for the various physical and psychological damages suffered, and resulting costs such as special care and. ....

Marine Martin , Sanofi News , Epilepsy Drug , Neuro Behavioural Disorders ,